CIK 0001427925 · Non-accelerated filer<br>Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 412193603
- Phone
- 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- 4 Grant or award Chief Engineering Officer acquired 14,667 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 18,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 58,667 shares (grant or award)
- 4 Shares withheld for taxes Chief Engineering Officer gave up 1,618 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 1,602 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,790 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 7,043 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 871 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $0.73 ($7,268)
- 4 Grant or award Director acquired 581 shares (grant or award)
- 4 Grant or award Director acquired 581 shares (grant or award)
- 4 Grant or award Director acquired 581 shares (grant or award)
- 4 Grant or award Director acquired 581 shares (grant or award)
- 4 Grant or award Director acquired 581 shares (grant or award)
- 4 Grant or award Director acquired 581 shares (grant or award)
- 4 Grant or award Director acquired 581 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $0.80 ($7,950)
Page 4 of 21 · 404 filings